Drug class
CNS stimulant and cholinergic precursor salt; deanol–N-acetyl-L-glutamate
Mechanism of action
A salt of deanol (2-dimethylaminoethanol) and N-acetyl-L-glutamate. Deanol is a choline-related precursor that has been proposed to influence acetylcholine availability and central cholinergic signalling; the pharmacological contribution of the aceglumate countercomponent and clinical mechanism are not well established.
General use cases
- Marketed in some countries for cognitive symptoms or neurological complaints, but clinical efficacy evidence and authorised indications are limited and jurisdiction-specific. It should not be presented as an established treatment for dementia or other neurodegenerative disease.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
